Source: Eur Respir J 2016; 47: 990-993



Rating:

Share or cite this content

Citations should be made in the following way:
Becker Katharina L., van Ingen Jakko, ten Oever Jaap, Merkus Peter J., Ferwerda Gerben, Netea Mihai G., Magis-Escurra Cecile, Reijers Monique H., van de Veerdonk Frank L.. Deficient interleukin-17 production in response to Mycobacterium abscessus in cystic fibrosis. Eur Respir J 2016; 47: 990-993

Member's Comments

No comment yet.

Related content which might interest you: Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020 Year: 2020 A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013 Clinical and immunological characteristics of patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Survival of Mycobacterium abscessus isolated from people with cystic fibrosis in artificially generated aerosols Source: Eur Respir J 2016; 48: 1789-1791 Year: 2016 Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018 Year: 2019 Inhaled granulocyte–macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis Source: Eur Respir J, 51 (4) 1702127; 10.1183/13993003.02127-2017 Year: 2018 Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Persistent non-tuberculous mycobacteria in cystic fibrosis Source: Virtual Congress 2020 – Paediatric respiratory diseases Year: 2020 Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 LATE-BREAKING ABSTRACT: Poor outcome following lung transplantation in CF patients infected with mycobacterium abscessus appears to be associated with two genetic clusters of mycobacterium abscessus subspecies abscessus Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Nontuberculous mycobacteria infection in patients with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 615s Year: 2004 Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy Source: Eur Respir J 2005; 25: 324-328 Year: 2005 Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021